Akut limfoid leukémia (ALL): vizsgálatok itt: Németország
36 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 17.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleInternational Study for Treatment of High Risk Childhood Relapsed ALL 2010
- Where
- Aachen, Augsburg, Berlin, Bielefeld, Bonn, Bremen, Brunswick, Cologne, Cottbus, Datteln, Dortmund, Dresden, Duesseldorf, Erfurt, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Goettingen, Greifswald, Halle Saale, Hamburg, Herdecke, Homburg, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Leipzig, Magdeburg, Mainz, Muenster, Munich, Oldenburg, Regensburg, Rostock, Sankt Augustin, Schwerin, Stuttgart, Tuebingen, Ulm, Wuerzburg
- Életkor
- Up to 17 év
- People
- 250 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT03590171 · EU 2024-513070-21-00 - 1. fázisTaking peopleLong-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
- Where
- Berlin, Dresden, Marburg, Munich, Ulm
- Életkor
- 18 év and over
- People
- 178
- Run by
- AvenCell Therapeutics, Inc.
See details and how to joinNCT07474051 · EU 2025-521717-67-00 - 1/2. fázisTaking peopleTafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia
- Where
- Berlin, Duesseldorf, Essen, Frankfurt Am Main, Freiburg, Hamburg, Hannover, Kiel, München, Tuebingen, Ulm, Wuerzburg
- Életkor
- 3 év to 18 év
- People
- 20
- Run by
- University Hospital Tuebingen
See details and how to joinNCT05366218 · EU 2024-511336-28-00 - No phaseTaking peopleEvaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Microscopy
- Where
- Erlangen
- Életkor
- 3 év to 17 év
- People
- 30
- Run by
- University of Erlangen-Nürnberg Medical School
See details and how to joinNCT07313878 - 1/2. fázisTaking peopleHEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
- Where
- Augsburg, Berlin, Essen, Frankfurt Am Main, Muenster
- Életkor
- 1 év to 21 év
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05658640 · EU 2022-501869-41-00 - 1/2. fázisTaking peopleHEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Where
- Augsburg, Berlin, Essen, Frankfurt Am Main, Muenster
- Életkor
- 1 év to 21 év
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05745714 · EU 2022-501867-42-01 - 1/2. fázisTaking peopleHEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Where
- Augsburg, Berlin, Essen, Frankfurt Am Main, Muenster
- Életkor
- 1 év to 21 év
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05751044 · EU 2022-501866-22-00 - 2. fázisTaking peopleRandomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT
- Where
- Aachen, Aschaffenburg, Augsburg, Bad Saarow, Bayreuth, Berlin, Bielefeld, Bochum, Bonn, Bremen, Brunswick, Chemnitz, Cologne, Cottbus, Darmstadt, Dessau-Rosslau, Dortmund, Dresden, Duesseldorf, Duisburg, Erlangen, Eschweiler, Essen, Frankfurt Am Main, Freiburg im Breisgau, Fulda, Georgsmarienhuette, Goch, Goettingen, Greifswald, Guetersloh, Hagen, Halle (Saale), Hamburg, Hamm, Hannover, Hanover, Heidelberg, Herne, Homburg, Idar-Oberstein, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Leipzig, Luedenscheid, Magdeburg, Mainz, Mannheim, Marburg, Meschede, Moenchengladbach, Muenster, Munich, Nuremberg, Offenburg, Oldenburg, Paderborn, Passau, Potsdam, Regensburg, Rostock, Schwaebisch Hall, Stuttgart, Traunstein, Trier, Tuebingen, Ulm, Villingen-Schwenningen, Wuerzburg, Wuppertal, Zwickau
- Életkor
- 18 év to 65 év
- People
- 220
- Run by
- Goethe University
See details and how to joinNCT06061094 · EU 2024-517966-40-00 - 3. fázisFut, nem toborozTreatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
- Where
- Aachen, Augsburg, Berlin, Brunswick, Chemnitz, Cologne, Cottbus, Datteln, Dortmund, Dresden, Duesseldorf, Erfurt, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Goettingen, Greifswald, Halle (Saale), Hanover, Heidelberg, Heilbronn, Herdecke, Homburg, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Leipzig, Luebeck, Magdeburg, Mannheim, Minden, Muenster, Munich, Nuernberg, Oldenburg, Regensburg, Rostock, Sankt Augustin, Schwerin, Stuttgart, Tuebingen, Ulm, Wolfsburg, Wuerzburg
- Életkor
- Up to 17 év
- People
- 5000 worldwide
- Run by
- Martin Schrappe
See details and how to joinNCT03643276 · EU 2023-509856-32-00 - No phaseTaking peopleDigital Health Promotion for Children With Congenital Heart Disease and Their Guardians
- Where
- München
- Életkor
- 8 év to 14 év
- People
- 60
- Run by
- Deutsches Herzzentrum Muenchen
See details and how to joinNCT06626672 - 1/2. fázisTaking peopleTreatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR
- Where
- Heidelberg
- Életkor
- 3 év and over
- People
- 68
- Run by
- University Hospital Heidelberg
See details and how to joinNCT03676504 · EU 2024-516832-82-00